GST rates slashed for certain cancer drugs - Video
|
Overview
New Delhi: In an effort to reduce the overall cost for the treatment of cancer, the GST Council decided to reduce the GST rate on certain cancer drugs from 12 per cent to 5 per cent in a meeting held on Monday. These drugs are Trastuzumab Deruxtecan, Osimertinib, and Durvalumab.
In another decision, GST rate has been reduced prospectively from 18 per cent to 12 per cent for namkeens and savoury items.
For more details, click the link below:
GST rates reduced from 12 percent to 5 per cent on certain cancer drugs
Speakers
With a graduation in Journalism and Mass Communication from Amity University, Yakshi Chugh embarked on a journey to explore the dynamic intersection of media and healthcare. In 2024, she joined Medical Dialogues, driven by a passion to enhance healthcare journalism and deliver insightful, impactful content to readers.
